News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) Launches New Microarray System to Simplify Immunogenetic Testing


6/29/2009 9:51:09 AM

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the commercial availability of a state-of-the-art, automated, research-use microarray system designed to simplify immunogenetic testing, including human leukocyte antigen (HLA) research. The new Prodigy™ system is an advanced DNA and protein analysis tool that simplifies and accelerates histocompatibility research, vaccine and drug development, and disease association studies.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES